Immix Biopharma, Inc. (IMMX)
12.74
+0.82
(+6.88%)
USD |
NASDAQ |
Sep 17, 16:00
12.72
-0.02
(-0.16%)
After-Hours: 20:00
Immix Biopharma Market Cap : 911.36M for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 16, 2026 | 852.71M |
| September 15, 2026 | 868.44M |
| September 14, 2026 | 873.45M |
| September 11, 2026 | 868.44M |
| September 10, 2026 | 908.50M |
| September 09, 2026 | 880.60M |
| September 08, 2026 | 947.85M |
| September 04, 2026 | 995.06M |
| September 03, 2026 | 989.34M |
| September 02, 2026 | 998.64M |
| September 01, 2026 | 1.002B |
| August 31, 2026 | 1.004B |
| August 28, 2026 | 997.21M |
| August 27, 2026 | 1.024B |
| August 26, 2026 | 1.007B |
| August 25, 2026 | 1.035B |
| August 24, 2026 | 973.60M |
| August 21, 2026 | 977.18M |
| August 20, 2026 | 941.41M |
| August 19, 2026 | 943.56M |
| August 18, 2026 | 844.84M |
| August 17, 2026 | 811.21M |
| August 14, 2026 | 784.75M |
| August 13, 2026 | 781.17M |
| August 12, 2026 | 813.36M |
| Date | Value |
|---|---|
| August 11, 2026 | 821.95M |
| August 10, 2026 | 724.66M |
| August 07, 2026 | 695.33M |
| August 06, 2026 | 719.65M |
| August 05, 2026 | 682.45M |
| August 04, 2026 | 494.60M |
| August 03, 2026 | 446.36M |
| July 31, 2026 | 441.06M |
| July 30, 2026 | 453.25M |
| July 29, 2026 | 433.11M |
| July 28, 2026 | 447.42M |
| July 27, 2026 | 460.68M |
| July 24, 2026 | 451.66M |
| July 23, 2026 | 466.51M |
| July 22, 2026 | 498.84M |
| July 21, 2026 | 507.33M |
| July 20, 2026 | 466.51M |
| July 17, 2026 | 543.37M |
| July 16, 2026 | 533.30M |
| July 15, 2026 | 558.22M |
| July 14, 2026 | 566.17M |
| July 13, 2026 | 557.69M |
| July 10, 2026 | 588.96M |
| July 09, 2026 | 587.90M |
| July 08, 2026 | 583.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Atossa Therapeutics, Inc. | 24.15M |
| ACADIA Pharmaceuticals, Inc. | 4.725B |
| Alnylam Pharmaceuticals, Inc. | 32.83B |
| Anika Therapeutics, Inc. | 280.91M |
| Savara, Inc. | 1.112B |
Market Cap Related Metrics
| PEG Ratio | -1.292 |
| Price to Book Value | 3.981 |
| Price | 12.74 |
| Earnings Yield | -6.91% |
| PEGY Ratio | -1.292 |